Definitive Hypofractionated Intensity-modulated Radiation Theraphy With Concurrent Chemotherapy in Cervical Cancer

NCT07439497 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

RADIATION: Definitive hypofractionated intensity-modulated radiation theraphy
DRUG: concurrent chemotherapy

Sponsor

Samsung Medical Center